multifuge
Multifuge (Piperazine Citrate) is a medication used to treat Ascariasis, Nematode Infections, Enterobiasis.
Piperazine Citrate · by Bluline
Key facts
- Active ingredient
- Piperazine Citrate
- Form
- Syrup
- Strength
- Piperazine Citrate EQ 500MG BASE/5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- ascariasis, nematode infections, enterobiasis
- Manufacturer
- Bluline
- FDA application
- NDA009452
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- ascariasis
- nematode infections
- enterobiasis
Dosage forms
Syrup
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Multifuge treat?
- Multifuge (Piperazine Citrate) may be used to treat ascariasis, nematode infections, enterobiasis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Multifuge?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Multifuge. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Multifuge?
- Multifuge is marketed by Bluline. You can see Bluline's full profile, rating, and other products on pharmaranks.
- Is Multifuge a brand-name or generic drug?
- Multifuge is a brand-name product with the active ingredient Piperazine Citrate.
- Is Multifuge available over the counter?
- No. Multifuge is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Multifuge come in?
- Multifuge is currently marketed as syrup, per the FDA's National Drug Code Directory.
- Is Multifuge FDA-registered?
- Multifuge is on record with the U.S. FDA under application number NDA009452. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about PIPERAZINE CITRATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 6 reports naming PIPERAZINE CITRATE — the active ingredient in Multifuge, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hereditary angioedema3 reports
- malaise3 reports
- poor venous access3 reports
- abdominal distension1 reports
- abdominal pain1 reports
- ascites1 reports
- constipation1 reports
- decreased appetite1 reports
Read these as a signal, not a rate. A report does not mean PIPERAZINE CITRATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 27, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Multifuge head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
multifuge
New